glp-1 medications approved for type 2 diabetes 2025 GLP-1s and Care: What We Learned at ADA Treating Type 2 Diabetes in

Works with Your Dietary Needs: Our Gut Healthy Prebiotic Bar is non-GMO, keto-friendly, soy-free, and made with no artificial ingredients

To ensure equitable progress against cancer worldwide, global medical research communities must collaborate to share best practices and implement innovative strategies tailored to local needs

Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at One Year: An Open Label, Non-Randomized, Controlled Study

[DOI] [Google Scholar] 120.Nakahara D., Nan C., Mori K., Hanayama M., Kikuchi H., Hirai S., Egashira Y

Advancing basal insulin replacement in type 2 diabetes inadequately controlled with insulin glargine plus oral agents: a comparison of adding albiglutide, a weekly GLP-1 receptor agonist, versus thrice-daily prandial insulin lispro

doi: 10.3389/fimmu.2025.1525623 Received 11 November 2024 Accepted 19 February 2025 Published 11 March 2025 Volume 16 - 2025 Edited by James Cheng-Chung Wei, Chung Shan Medical University Hospital, Taiwan Reviewed by Venkateswarlu Kanamarlapudi, Swansea University Medical School, United Kingdom Ching-Hua Huang, Chung Shan Medical University Hospital, Taiwan Updates Copyright 2025 Sun, Hao, Liu and Gao